UPDATE 1-Sanofi loses Lantus patent claims against Mylan
December 13, 2018 at 09:04 AM EST
U.S. generics drugmaker Mylan N.V. said on Thursday the U.S. Patent and Trademark Office rejected French pharma company Sanofi's patent infringement claims related to two formulations of its blockbuster insulin drug Lantus.